Home›Stock Screener›Vivanza Biosciences›Quarterly Results

Vivanza Biosciences Quarterly Results

Latest Quarter Net Profit
₹0 Cr
QSept 2026
Quarterly Results

Vivanza Biosciences quarterly results. In Sept 2026, Vivanza Biosciences (VIVANZA) reported revenue ₹11 Cr and net profit ₹0 Cr — revenue -80.0% YoY. View VIVANZA 52-week high low for the annual high/low range and current price position.

VIVANZA Quarterly Results — Revenue, Profit & EPS Highlights

Vivanza Biosciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore Vivanza Biosciences stock price data download to track price trends across different timeframes.

  • Revenue of ₹11 Cr in Sept 2026 (+83.3% vs Mar 2026, -80.0% vs Sept 2025)
  • Operating Margin of 2.0% in Sept 2026 (+6.0pp vs Mar 2026)
  • Earnings Per Share of ₹0.03 in Sept 2026 (+127.3% vs Mar 2026)

Vivanza Biosciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

VIVANZA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 11 6 10 55 1 83.3% -80.0%
Net Profit (₹ Cr) 0 0 0 1 -1 - -
EBITDA (₹ Cr) 0 0 0 1 -1 - -
EPS (₹) 0.03 -0.11 0.04 0.14 -0.25 - -
Operating Margin (%) 2.0% -4.0% -1.0% 1.0% -200.0% - -

VIVANZA Share Price Trend — 1-Year Movement Across Quarterly Results

Vivanza Biosciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit VIVANZA share price screener.

Profitability Ratios

Operating Margin 2.0%

Balance Sheet Highlights

Total Assets ₹22 Cr
Total Equity ₹4 Cr
Current Assets ₹ Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹-3 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹3 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹1.44
Exchange BSE
Last Updated Nov 19, 2026

VIVANZA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Vivanza Biosciences latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores